DNLIDenali Therapeutics Inc.Healthcare · Biotechnologyas of 2026-09-25
Horizon

Issued 2026-09-25 at $20.39 · now $20.39 (2026-09-25, +0.0% since)

Based on its own history, a month from the 2026-09-25 close, DNLI has typically landed between $15.90 and $25.89 — a range of −22.0% to +27.0% from the issuance price $20.39.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.
  • Actual close
  • Typical path (median)
  • Middle 50% of outcomes
  • 90% range

2,189 overlapping 1 month windows · 2017-12-08 – 2026-08-26 · basis climatology · forecast (batch). Base rate up 53.7% (90% CI 51.5–55.9%, ≈1,391 obs). Not a call on this stock — we have no evidence its odds differ.

The cone is anchored at the 2026-09-25 issuance close ($20.39) — the price the forecast resolves against on 2026-10-26, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

Where DNLI has typically landed a month from the 2026-09-25 close of $20.39 — the range is history, not a prediction.

$15.9worst · -22.0%$25.89best · +27.0%
  • now $20.39 (+0.0%)
  • typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $20.23 (-0.8%)
  • middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $18.2–$22.25
  • 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $15.9–$25.89
Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 2,189 windows spanning 2017-12-08 to 2026-09-25. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.
StartReturnMax dropMax rise
3 worst
2020-02-13−44.4%−44.4%+2.7%
2020-02-11−39.0%−39.0%+6.6%
2020-02-18−37.3%−45.8%+0.0%
3 best
2022-06-16+69.6%+0.0%+69.6%
2022-06-14+61.9%−0.2%+61.9%
2020-10-14+60.7%−8.8%+60.7%

2,189 overlapping windows · 2017-12-08 – 2026-09-25 · not cherry-picked

Pending catalysts

  • December 2026 — Trial primary completion: Phase 1/Phase PHASE2 primary completion: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL593 in Healthy Participants and Participants With Frontotemporal Dementia (FTD-GRN) (source, as of 2026-08-14)
  • March 2027 — Trial primary completion: Phase 2 primary completion: Safety and Pharmacodynamic Effects of BIIB122 in Participants With LRRK2-Associated Parkinson's Disease (LRRK2-PD) (source, as of 2026-08-14)
  • June 2027 — Trial primary completion: Phase 2/Phase PHASE3 primary completion: An Extension Study of the Long-Term Safety, Tolerability, and Efficacy of Tividenofusp Alfa (DNL310) in Participants With Mucopolysaccharidosis Type II (MPS II) From Study DNLI-E-0002 or Study DNLI-E-0007 (source, as of 2026-08-14)
  • December 2027 — Trial primary completion: Phase 2/Phase PHASE3 primary completion: A Study to Determine the Efficacy and Safety of Tividenofusp Alfa (DNL310) vs Idursulfase in Pediatric and Young Adult Participants With Neuronopathic (nMPS II) or Non-Neuronopathic Mucopolysaccharidosis Type II (nnMPS II) (source, as of 2026-08-14)
  • August 2028 — Trial primary completion: Phase 1/Phase PHASE2 primary completion: Study of DNL126 in Pediatric Participants With Mucopolysaccharidosis Type IIIA (Sanfilippo Syndrome Type A) (source, as of 2026-08-14)
  • February 2031 — Trial primary completion: Phase 1/Phase PHASE2 primary completion: A Study of Tividenofusp Alfa (DNL310) in Pediatric Participants With Hunter Syndrome (source, as of 2026-08-14)

Public, scheduled events — dated attention, not a prediction of the outcome. See the FDA catalysts page for the historical base rate.

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~9 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.
Jan
56%
+6.9%
n=9
Feb
33%
−2.3%
n=9
Mar
22%
−8.8%
n=9
Apr
56%
+0.8%
n=9
May
78%
+5.6%
n=9
Jun
67%
+7.8%
n=9
Jul
33%
−5.3%
n=9
Aug
67%
+6.4%
n=9
Sep
44%
+0.4%
n=9
Oct
38%
−3.7%
n=8
Nov
63%
+13.7%
n=8
Dec
38%
+1.1%
n=8

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Share price & reported tradesMonthly open-market valueReporting lag — trade date to filing date2026-092026-082026-072026-062026-052026-042026-032026-022026-012025-122025-112025-102025-092025-08$27$132026-09-04: 1 insider sale, $37K — Chin Peter Scott2026-09-02: 2 insider sales, $262K — Thornberry Nancy …2026-09-01: 1 insider sale, $65K — Schuth Alexander O.2026-08-11: 1 insider sale, $72K — Schuth Alexander O.2026-01-06: 2 insider sales, $865K — Watts Ryan J., Schuth Alexander O.2025-12-11: 2 insider purchases, $40.0M — BAKER BROS. ADVISORS LP …2025-08: 3 open-market sales, $92K2025-12: 2 open-market purchases, $40.0M2026-01: 2 open-market sales, $865K2026-09: 4 open-market sales, $364K↑ buys↓ salesofficer Chin Peter Scott — Sale on 2026-09-04, filed 5 days after the tradedirector Thornberry Nancy — Sale on 2026-09-02, filed 2 days after the tradedirector Thornberry Nancy — Sale on 2026-09-02, filed 2 days after the tradeofficer Schuth Alexander O. — Sale on 2026-09-01, filed 2 days after the tradeofficer Schuth Alexander O. — Sale on 2026-08-11, filed 2 days after the tradedirector Watts Ryan J. — Sale on 2026-01-06, filed 2 days after the tradeofficer Schuth Alexander O. — Sale on 2026-01-06, filed 2 days after the tradedirector BAKER BROS. ADVISORS LP — Purchase on 2025-12-11, filed 4 days after the tradedirector BAKER BROS. ADVISORS LP — Purchase on 2025-12-11, filed 4 days after the trade
DatePersonRoleActionShares @ priceValueOwnership Δvs S&P 1mvs S&P 6mOwned afterFiling
2026-09-04Chin Peter ScottofficerSale1,654 @ $22.29$37K−0.8% of holdingnot yet — horizon still opennot yet — horizon still open204,538Form 4 · filed 5 days after the trade
2026-09-02Thornberry NancydirectorSale10,824 @ $22.85$247K−34.8% of holdingnot yet — horizon still opennot yet — horizon still open20,301Form 4 · filed 2 days after the trade
2026-09-02Thornberry NancydirectorSale615 @ $23.74$15K−3.0% of holdingnot yet — horizon still opennot yet — horizon still open19,686Form 4 · filed 2 days after the trade
2026-09-01Schuth Alexander O.officerSale2,768 @ $23.44$65K−1.0% of holdingnot yet — horizon still opennot yet — horizon still open278,995Form 4 · filed 2 days after the trade
2026-08-11Schuth Alexander O.officerSale2,857 @ $25.07$72K−1.0% of holding−11.7%not yet — horizon still open281,763Form 4 · filed 2 days after the trade
2026-01-06Watts Ryan J.directorSale35,198 @ $16.50$581K−10.6% of holding+18.4%+48.9%296,833Form 4 · filed 2 days after the trade
2026-01-06Schuth Alexander O.officerSale17,218 @ $16.50$284K−5.7% of holding+18.4%+48.9%282,828Form 4 · filed 2 days after the trade
2025-12-11BAKER BROS. ADVISORS LPdirectorPurchase2,095,191 @ $17.49$36.6M+8.8% of holding+3.3%+17.8%25,996,310Form 4 · filed 4 days after the trade
2025-12-11BAKER BROS. ADVISORS LPdirectorPurchase190,523 @ $17.49$3.3M+8.9% of holding+3.3%+17.8%2,335,469Form 4 · filed 4 days after the trade
2025-08-13Ho CaroledirectorSale806 @ $14.64$12K−0.4% of holding−6.1%+23.3%216,585Form 4 · filed 1 day after the trade
2025-08-12Schuth Alexander O.officerSale2,937 @ $13.58$40K−1.2% of holding+9.8%+40.7%242,346Form 4 · filed 2 days after the trade
2025-08-12Ho CaroledirectorSale2,937 @ $13.58$40K−1.3% of holding+9.8%+40.7%217,391Form 4 · filed 2 days after the trade
2025-07-09Watts Ryan J.directorSale495,282 @ $15.00$7.4M−66.2% of holding−6.4%+1.9%253,071Form 4 · filed 2 days after the trade
2025-01-07Watts Ryan J.directorSale7,650 @ $20.81$159K−2.9% of holding+3.0%−38.0%253,071Form 4 · filed 1 day after the trade
2025-01-07Krognes Steve E.directorSale3,339 @ $20.81$69K−11.5% of holding+3.0%−38.0%25,757Form 4 · filed 1 day after the trade
2025-01-07Ho CaroledirectorSale2,907 @ $20.81$60K−1.6% of holding+3.0%−38.0%175,673Form 4 · filed 1 day after the trade
2025-01-07Schuth Alexander O.officerSale2,907 @ $20.81$60K−1.2% of holding+3.0%−38.0%244,308Form 4 · filed 1 day after the trade
2025-01-06Watts Ryan J.directorSale29,266 @ $20.22$592K−10.1% of holding+11.8%−28.3%260,721Form 4 · filed 2 days after the trade
2025-01-06Ho CaroledirectorSale12,255 @ $20.22$248K−6.4% of holding+11.8%−28.3%178,580Form 4 · filed 2 days after the trade
2025-01-06Schuth Alexander O.officerSale12,255 @ $20.22$248K−4.7% of holding+11.8%−28.3%247,215Form 4 · filed 2 days after the trade
2025-01-02SATO VICKI LdirectorSale3,080 @ $20.91$64K−2.8% of holding+7.4%−38.0%107,976Form 4 · filed 1 day after the trade
2024-12-31Krognes Steve E.directorSale30,000 @ $20.25$608K−50.8% of holding+5.2%−36.6%29,096Form 4 · filed 3 days after the trade
2024-11-11Schenkein David PdirectorSale32,312 @ $32.87$1.1M−77.8% of holding−25.9%−54.4%9,220Form 4 · filed 2 days after the trade
2024-11-11Schenkein David PdirectorSale27,129 @ $32.09$871K−39.5% of holding−25.9%−54.4%41,532Form 4 · filed 2 days after the trade
2024-11-07Schuth Alexander O.officerSale12,333 @ $29.68$366K−6.4% of holding−17.2%−51.0%181,291Form 4 · filed 5 days after the trade
2024-11-07Schuth Alexander O.officerSale2,925 @ $30.72$90K−1.6% of holding−17.2%−51.0%178,366Form 4 · filed 5 days after the trade
2024-11-07SATO VICKI LdirectorSale1,020 @ $30.00$31K−0.9% of holding−17.2%−51.0%111,056Form 4 · filed 5 days after the trade
2024-11-07Schuth Alexander O.officerSale300 @ $31.29$9K−0.2% of holding−17.2%−51.0%178,066Form 4 · filed 5 days after the trade
2024-11-01SATO VICKI LdirectorSale3,080 @ $27.07$83K−2.7% of holding−17.4%−46.0%112,076Form 4 · filed 4 days after the trade
2024-10-18Watts Ryan J.directorSale40,000 @ $27.69$1.1M−14.5% of holding−13.0%−38.3%235,807Form 4 · filed 4 days after the trade
2024-09-30Krognes Steve E.directorSale30,000 @ $29.03$871K−50.8% of holding−7.1%−51.9%29,096Form 4 · filed 2 days after the trade
2024-09-13SATO VICKI LdirectorSale1,020 @ $30.00$31K−0.9% of holding−17.1%−53.3%115,156Form 4 · filed 3 days after the trade
2024-09-03SATO VICKI LdirectorSale2,980 @ $24.99$74K−2.5% of holding+12.2%−39.6%116,276Form 4 · filed 1 day after the trade
2024-09-03SATO VICKI LdirectorSale100 @ $25.37$3K−0.1% of holding+12.2%−39.6%116,176Form 4 · filed 1 day after the trade
2024-08-21Ho CaroledirectorSale14,098 @ $24.41$344K−10.2% of holding+22.0%−24.5%124,717Form 4 · filed 1 day after the trade
2024-08-21Ho CaroledirectorSale5,907 @ $24.96$147K−4.7% of holding+22.0%−24.5%118,810Form 4 · filed 1 day after the trade
2024-08-21Schuth Alexander O.officerSale2,547 @ $24.78$63K−1.4% of holding+22.0%−24.5%178,066Form 4 · filed 1 day after the trade
2024-08-20Schuth Alexander O.officerSale3,353 @ $23.54$79K−1.8% of holding+29.1%−20.4%180,613Form 4 · filed 2 days after the trade
2024-08-20Schuth Alexander O.officerSale2,453 @ $23.79$58K−1.3% of holding+29.1%−20.4%183,966Form 4 · filed 2 days after the trade
2024-08-20Ho CaroledirectorSale2,453 @ $23.79$58K−1.7% of holding+29.1%−20.4%138,815Form 4 · filed 2 days after the trade
2024-08-20Watts Ryan J.directorSale2,260 @ $23.79$54K−0.9% of holding+29.1%−20.4%235,807Form 4 · filed 2 days after the trade
2024-08-20Krognes Steve E.directorSale1,727 @ $23.79$41K−5.0% of holding+29.1%−20.4%32,677Form 4 · filed 2 days after the trade
2024-08-13Ho CaroledirectorSale2,337 @ $22.89$53K−1.6% of holding+18.3%−20.6%141,268Form 4 · filed 2 days after the trade
2024-08-13Schuth Alexander O.officerSale2,272 @ $22.89$52K−1.2% of holding+18.3%−20.6%186,419Form 4 · filed 2 days after the trade
2024-07-01Krognes Steve E.directorSale29,900 @ $22.12$661K−46.4% of holding+9.7%−16.6%34,504Form 4 · filed 2 days after the trade
2024-07-01SATO VICKI LdirectorSale2,980 @ $22.12$66K−2.4% of holding+9.7%−16.6%119,356Form 4 · filed 2 days after the trade
2024-07-01SATO VICKI LdirectorSale100 @ $22.86$2K−0.1% of holding+9.7%−16.6%119,256Form 4 · filed 2 days after the trade
2024-07-01Krognes Steve E.directorSale100 @ $22.80$2K−0.3% of holding+9.7%−16.6%34,404Form 4 · filed 2 days after the trade
2024-06-13Krognes Steve E.directorSale688 @ $21.79$15K−1.3% of holding+3.8%−6.0%52,620Form 4 · filed 20 days after the trade
2024-06-06Cook Jennifer E.directorSale1,458 @ $21.73$32K−6.8% of holding−5.9%−4.7%20,038Form 4 · filed 4 days after the trade
2024-05-15SATO VICKI LdirectorSale1,674 @ $20.39$34K−1.4% of holding−3.1%+28.6%116,369Form 4 · filed 2 days after the trade
2024-04-15SATO VICKI LdirectorSale1,666 @ $18.29$30K−1.4% of holding+7.0%+33.8%118,043Form 4 · filed 2 days after the trade
2024-04-01Krognes Steve E.directorSale92,500 @ $20.50$1.9M−66.1% of holding−21.0%+31.1%47,341Form 4 · filed 1 day after the trade
2024-03-15SATO VICKI LdirectorSale1,666 @ $20.10$33K−1.4% of holding−12.6%+39.9%119,709Form 4 · filed 4 days after the trade
2024-02-15SATO VICKI LdirectorSale1,666 @ $18.37$31K−1.4% of holding+6.9%+14.3%121,375Form 4 · filed 5 days after the trade

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

85 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

DatePersonRoleActionSharesOwned afterFiling
2026-08-12Watts Ryan J.directorGift32,2202,120,384Form 4
2026-06-03Klein Peter SdirectorAward / grant19,22619,226Form 4
2026-06-03Schenkein David PdirectorAward / grant6,40821,665Form 4
2026-06-03Schenkein David PdirectorAward / grant19,22619,226Form 4
2026-06-03Krognes Steve E.directorAward / grant6,40838,202Form 4
2026-06-03Krognes Steve E.directorAward / grant19,22619,226Form 4
2026-06-03Thornberry NancydirectorAward / grant6,40831,125Form 4
2026-06-03Thornberry NancydirectorAward / grant19,22619,226Form 4
2026-06-03Van Hauwermeiren TimothydirectorAward / grant6,40817,040Form 4
2026-06-03Van Hauwermeiren TimothydirectorAward / grant19,22619,226Form 4
2026-06-03BAKER BROS. ADVISORS LPdirectorAward / grant19,22619,226Form 4
2026-06-03Cook Jennifer E.directorAward / grant6,40832,483Form 4
2026-06-03BAKER BROS. ADVISORS LPdirectorAward / grant6,408343,275Form 4
2026-06-03Cook Jennifer E.directorAward / grant19,22619,226Form 4
2026-06-03FLATLEY JAY TdirectorAward / grant6,40822,628Form 4
2026-06-03FLATLEY JAY TdirectorAward / grant19,22619,226Form 4
2026-06-03Klein Peter SdirectorAward / grant6,40833,941Form 4
2026-06-03BAKER BROS. ADVISORS LPdirectorAward / grant6,4083,422,366Form 4
2026-01-03Watts Ryan J.directorAward / grant78,960332,031Form 4
2026-01-03Watts Ryan J.directorAward / grant236,880236,880Form 4
2026-01-03Schuth Alexander O.officerAward / grant57,700300,046Form 4
2026-01-03Schuth Alexander O.officerAward / grant173,100173,100Form 4
2025-11-04Van Hauwermeiren TimothydirectorAward / grant10,63210,632Form 4
2025-11-04Van Hauwermeiren TimothydirectorAward / grant31,89731,897Form 4
2025-09-03Watts Ryan J.directorGift50,0002,152,604Form 4
2025-08-05Ho CaroledirectorOption exercise44,655220,328Form 4
2025-08-05Ho CaroledirectorOption exercise44,65562,500Form 4
2025-07-09Watts Ryan J.directorOption exercise455,282708,353Form 4
2025-07-09Watts Ryan J.directorOption exercise40,000748,353Form 4
2025-07-09Watts Ryan J.directorOption exercise40,00020,369Form 4
2025-07-09Watts Ryan J.directorOption exercise455,282622,809Form 4
2025-06-03Klein Peter SdirectorAward / grant6,03727,533Form 4
2025-06-03Klein Peter SdirectorAward / grant18,11118,111Form 4
2025-06-03Cook Jennifer E.directorAward / grant6,03726,075Form 4
2025-06-03Cook Jennifer E.directorAward / grant18,11118,111Form 4
2025-06-03Thornberry NancydirectorAward / grant6,03724,717Form 4
2025-06-03Tessier-Lavigne MarcdirectorAward / grant6,0371,886,576Form 4
2025-06-03Tessier-Lavigne MarcdirectorAward / grant18,11118,111Form 4
2025-06-03BAKER BROS. ADVISORS LPdirectorAward / grant10,565336,867Form 4
2025-06-03BAKER BROS. ADVISORS LPdirectorAward / grant10,5653,415,958Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.